GlassScriptPhysician profile
Rodney J Herrin
NPI 1407835457
$18,794.81
in general payments reported to CMS, 2019-2025
9 companies · $140 in 2025
The $140 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,709 · 2020: $1,783 · 2021: $4,109 · 2022: $6,147 · 2023: $719 · 2024: $1,187 · 2025: $140.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,214 · Travel and Lodging: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,214.25 |
| Travel and Lodging | $832.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,327.19 | 2019-2022 | |
| Wardlow Enterprises | $3,584.00 | 2019-2022 | |
| Medical Device Business Services, INC. | $2,667.44 | 2020-2024 | Inhance |
| Zimmer Biomet Holdings, INC. | $2,062.63 | 2019-2025 | Avenir, Persona |
| Depuy Synthes Sales INC. | $1,698.39 | 2019-2024 | Velys, Kincise, Inhance |
| Pacira Therapeutics, INC. | $208.08 | 2020-2021 | |
| Vericel Corporation | $154.08 | 2022 | |
| Smith+Nephew, INC. | $75.80 | 2019 | |
| Orthofix Medical, INC. | $17.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rodney Herrin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.